Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.69% | 342.85 | 1.2% | $619.74m | |
| GILD | Gilead Sciences, Inc. | -0.78% | 72.35 | 0.9% | $506.72m | |
| CELG | Celgene Corporation | -0.48% | 89.94 | 1.2% | $494.04m | |
| AMGN | Amgen Inc. | -0.17% | 197.09 | 1.2% | $484.53m | |
| ILMN | Illumina, Inc. | 0.13% | 326.30 | 3.5% | $374.18m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.53% | 372.28 | 2.6% | $314.11m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.06% | 174.22 | 1.9% | $206.87m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.07% | 116.08 | 2.0% | $186.71m | |
| A | Agilent Technologies, Inc. | 0.11% | 64.73 | 1.5% | $159.45m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.43% | 129.69 | 16.6% | $141.85m | |
| NKTR | Nektar Therapeutics | 0.23% | 60.17 | 5.6% | $126.58m | |
| BLUE | Bluebird Bio, Inc. | -0.29% | 157.55 | 14.6% | $121.23m | |
| EXAS | Exact Sciences Corporation | -0.85% | 48.43 | 25.3% | $117.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.17% | 98.82 | 4.4% | $116.17m | |
| INCY | Incyte Corporation | -0.39% | 68.53 | 2.5% | $111.30m |
Company Profile
Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.